EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dexamethasone and OLT1177 Cooperate in the Reduction of Melanoma Growth by Inhibiting STAT3 Functions

Alberto Dinarello iD, Taylor S Mills, Isak W Tengesdal, Nicholas E Powers iD, Tania Azam, Charles A Dinarello

Cells · 2023

DOI: 10.3390/cells12020294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Alberto Dinarello und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Colorado, Aurora, Denver, CO 80045, USA. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Melanoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, United States NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The NLRP3 inflammasome is a multimolecular complex that processes inactive IL-1β and IL-18 into proinflammatory cytokines. OLT1177 is an orally active small compound that specifically inhibits NLRP3. Here, B16F10 melanoma were implanted in mice and treated with OLT1177 as well as combined with the glucocorticoid dexamethasone. At sacrifice, OLT1177 treated mice had significantly smaller tumors compared to tumor-bearing mice treated with vehicle. However, the combined treatment of OLT1177 plus dexamethasone revealed a greater suppression of tumor growth. This reduction was accompanied by a downregulation of nuclear and mitochondrial STAT3-dependent gene transcription and by a significant reduction of STAT3 Y705 and S727 phosphorylations in the tumors. In vitro, the human melanoma cell line 1205Lu, stimulated with IL-1α, exhibited significantly lower levels of STAT3 Y705 phosphorylation by the combination treatment, thus affecting the nuclear functions of STAT3. In the same cells, STAT3 serine 727 phosphorylation was also lower, affecting the mitochondrial functions of STAT3. In addition, metabolic analyses revealed a marked reduction of ATP production rate and glycolytic reserve in cells treated with the combination of OLT1177 plus dexamethasone. These findings demonstrate that the combination of OLT1177 and dexamethasone reduces tumor growth by targeting nuclear as well as mitochondrial functions of STAT3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinMelanomaHumansAnimalsMiceInflammasomesDexamethasoneSTAT3 Transcription FactorNitrilesSulfones

Stichwörter der Autor:innen

InflammasomeSTAT3dexamethasonemelanoma

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesDexamethasoneSTAT3 Transcription FactordapansutrileNitrilesSulfonesSTAT3 protein, human

Autor:innen und Institutionen

  • Department of Medicine, University of Colorado, Aurora, Denver, CO 80045, USA.
  • Department of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS), Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

ORCID-Profile: Alberto Dinarello, Nicholas E Powers

Förderung

  • NIAID NIH HHS
  • United States NIH

Zitieren

APA

Dinarello, A., Mills, T. S., Tengesdal, I. W., Powers, N. E., Azam, T., & Dinarello, C. A. (2023). Dexamethasone and OLT1177 Cooperate in the Reduction of Melanoma Growth by Inhibiting STAT3 Functions. Cells. https://doi.org/10.3390/cells12020294

Vancouver

Dinarello A, Mills TS, Tengesdal IW, Powers NE, Azam T, Dinarello CA. Dexamethasone and OLT1177 Cooperate in the Reduction of Melanoma Growth by Inhibiting STAT3 Functions. Cells. 2023. doi:10.3390/cells12020294

BibTeX
@article{Dinarello2023,
  author = {Dinarello, Alberto and Mills, Taylor S and Tengesdal, Isak W and Powers, Nicholas E and Azam, Tania and Dinarello, Charles A},
  title = {Dexamethasone and OLT1177 Cooperate in the Reduction of Melanoma Growth by Inhibiting STAT3 Functions},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12020294}
}
Kostenlos starten →